Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $122.19 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $82.83 | 1 | $0 (2021) |
| Abbott Laboratories | $39.36 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.14 | 1 | Abbott Laboratories ($21.14) |
| 2023 | $18.22 | 1 | Abbott Laboratories ($18.22) |
| 2021 | $82.83 | 1 | Novo Nordisk Inc ($82.83) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Diabetes Care | ||||||
| 10/29/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Diabetes Care | ||||||
| 06/25/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $82.83 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,039 | 1,349 | $321,507 | $99,969 |
| 2022 | 20 | 1,591 | 2,036 | $316,644 | $100,391 |
| 2021 | 21 | 1,780 | 2,347 | $307,103 | $105,279 |
| 2020 | 15 | 1,205 | 1,816 | $284,975 | $86,397 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 245 | 377 | $159,096 | $41,816 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 215 | 301 | $91,300 | $24,130 | 26.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 29 | $9,280 | $7,887 | 85.0% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 57 | 57 | $13,110 | $7,323 | 55.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 96 | 96 | $10,669 | $6,339 | 59.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 103 | 103 | $5,640 | $3,004 | 53.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 47 | $9,600 | $2,495 | 26.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 57 | 57 | $3,135 | $2,238 | 71.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $3,134 | $1,355 | 43.2% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 22 | 22 | $1,100 | $863.94 | 78.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 29 | 29 | $1,495 | $824.60 | 55.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 16 | 18 | $2,217 | $500.16 | 22.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 19 | 37 | $4,958 | $434.82 | 8.8% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 32 | 78 | $2,106 | $419.52 | 19.9% |
| 85610 | Blood test, clotting time | Office | 2023 | 25 | 48 | $4,032 | $201.60 | 5.0% |
| 90471 | Administration of vaccine | Office | 2023 | 12 | 12 | $635.00 | $136.53 | 21.5% |
| 91312 | Sarscov2 vac bvl 30mcg/0.3ml | Office | 2023 | 27 | 27 | $0.27 | $0.27 | 100.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 239 | 376 | $151,052 | $40,562 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 222 | 307 | $88,087 | $21,683 | 24.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 120 | 122 | $6,832 | $6,649 | 97.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 18 | $5,560 | $4,962 | 89.2% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 131 | 131 | $6,550 | $4,902 | 74.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 134 | 136 | $6,800 | $3,825 | 56.2% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 101 | 101 | $5,050 | $3,810 | 75.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 27 | 27 | $8,650 | $3,415 | 39.5% |
About Dr. Christopher Yusko, D.O
Dr. Christopher Yusko, D.O is a Internal Medicine healthcare provider based in Mount Pocono, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649223405.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Yusko, D.O has received a total of $122.19 in payments from pharmaceutical and medical device companies, with $21.14 received in 2024. These payments were reported across 3 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($122.19).
As a Medicare-enrolled provider, Yusko has provided services to 5,615 Medicare beneficiaries, totaling 7,548 services with total Medicare billing of $392,036. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Mount Pocono, PA
- Active Since 05/19/2006
- Last Updated 07/30/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1649223405
Products in Payments
- RYBELSUS (Drug) $82.83
- FREESTYLE LIBRE 3 (Device) $39.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.